Impact of Weight Loss Surgery in Adolescents With NAFLD (AWLS)
The Impact of Weight Loss Surgery in Adolescents on Fatty Liver Disease
Sponsor: Massachusetts General Hospital
Listed as NCT02952170, this NA trial focuses on NAFLD and Obesity, Adolescent and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Nov 2022 — Apr 2023 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Nov 2018 — Nov 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
For direct contact, visit the study record on ClinicalTrials.gov .